ALK-Abelló (CPSE:ALK B) has quietly delivered a strong run for shareholders this year, and that momentum is forcing investors to revisit what they are willing to pay for this allergy specialist. See ...
Zacks Investment Research on MSN
Alaska Air Group (ALK) stock drops despite market gains: Important facts to note
Alaska Air Group (ALK) ended the recent trading session at $51.18, demonstrating a -4.3% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of ...
20 August 2026: Six-month interim report (Q2) 2026 ...
Recent studies offer new insights into ALK detection methods and related treatments. Screening for the non-small cell lung cancer (NSCLC) subtype has been at the forefront of NSCLC research, and ...
Anaplastic lymphoma kinase (ALK) is involved in the initiation and progression of many different cancer types, including lymphomas, neuroblastoma and non-small-cell lung cancer. It is clear that ALK ...
If you or a loved one has lung cancer, you may be looking into different treatment options. One new medicine you may hear about is Ensacove (ensartinib). In December 2024, the FDA approved Ensacove as ...
There are many treatment options for lung cancer, but the right one for you will depend on many factors including the type of lung cancer you have. Non-small-cell lung cancer (NSCLC) is the most ...
Progression-Free Survival in Patients With Cholangiocarcinoma With or Without FGF/FGFR Alterations: A FIGHT-202 Post Hoc Analysis of Prior Systemic Therapy Response Primary tumor sites were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback